Skip to main content
HIT
NASDAQ Finance

Health In Tech 10-Q: $6.1M Credit-Loss Charge Drives $11.2M Nine-Month Net Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$0.402
Mkt Cap
$25.826M
52W Low
$0.365
52W High
$2.1
52W Position info
10% above low
Off High info
81% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HIT is trading near its 52-week low of $0.365 (10% above the low).

Summary

Health In Tech's Q3 10-Q details a $6.07 million nine-month credit-loss provision that drove an $11.2 million net loss and negative $7.28 million operating cash flow, with $9.75 million of Yorkville convertible notes outstanding and a Nasdaq bid-price deficiency to cure by April 12, 2027.


Key Events · Earnings and Guidance · HIT

  • Q3 Revenue Falls 22% to $6.6M

    Q3 2026 revenue was $6,587,052 versus $8,490,093 a year ago; nine-month revenue was $23,415,318 versus $25,818,926, with the company citing delayed policy starts from a carrier transition.

  • $6.1M Credit-Loss Provision Drives Loss

    Nine-month provision for credit losses was $6,074,587, including a $3,124,995 full reserve on the 2025 Deferred Administrative Surplus purchase and an $863,992 full reserve on the Kang Youle loan; net loss attributable to common stockholders was $11,165,718, or $(0.18) per share.

  • Operating Cash Flow Turns Negative

    Net cash used in operating activities was $7,277,043 for the nine months versus $2,682,602 provided a year earlier; cash and equivalents were $10,127,237 at September 30, 2026.

  • $9.75M Yorkville Notes Outstanding

    The First Convertible Note ($7.0M principal, $6,639,108 fair value) plus the $3,000,000 second note issued November 2, 2026 (net proceeds $2,850,000) total $9,750,000 outstanding; SEPA proceeds must repay the notes while they remain outstanding.


Analysis · HIT · Finance

The Q3 headline numbers were already out on November 12, but the full 10-Q reveals the depth of the credit problem: a $6.07 million nine-month provision for credit losses, including a full $3.12 million reserve against the 2025 Deferred Administrative Surplus purchase and a full $863,992 reserve against the Kang Youle loan. Operating cash flow flipped to negative $7.28 million from positive $2.68 million a year earlier, and the company is leaning on Yorkville convertible notes — $9.75 million outstanding after the November 2 second tranche — with SEPA proceeds required to repay them. Against a $0.40 stock and an October 12 Nasdaq bid-price deficiency that must be cured by April 12, 2027, the balance sheet is the story.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HIT was trading at $0.40 on NASDAQ in the Finance sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $0.36 to $2.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HIT - Latest Insights

HIT
Nov 13, 2026, 5:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4017
Real-time Price: $0.399 info
Change: -$0.0027 (-0.67%) info
Market Cap: $25.826M info
HIT
Nov 12, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.540
Real-time Price: $0.399 info
Change: -$0.141 (-26%) info
Market Cap: $25.826M info
HIT
Nov 12, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.399 info
Change: -$0.151 (-27%) info
Market Cap: $25.826M info
HIT
Nov 06, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5574
Real-time Price: $0.399 info
Change: -$0.1584 (-28%) info
Market Cap: $25.826M info
HIT
Oct 28, 2026, 5:23 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $0.5703
Real-time Price: $0.399 info
Change: -$0.1713 (-30%) info
Market Cap: $25.826M info